Vicarious Surgical
Stock Forecast, Prediction & Price Target

Vicarious Surgical (RBOT) stock Price Target by analysts

Last Year
Average Price Target

$10.5

Potential upside: 61.29%

Based on 1 analysts

Vicarious Surgical price prediction

Strike.market

What is Vicarious Surgical stock analysts` prediction?

Vicarious Surgical stock forecast: Based on 1 Wall Street analysts` predicted price targets for Vicarious Surgical in the last 3 months, the avarage price target is $10.5, with a high forecast of $NaN. The average price target represents a 61.29% change from the last price of $6.51.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Vicarious Surgical stock Price Target by analysts

Full breakdown of analysts given Vicarious Surgical price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Adam Maeder
Piper Sandler
0%
0/1
10 months ago $10.5 61.29% upside $6.07 StreetInsider
Previous targets (0)
Unknown
BTIG
N/A
about 3 years ago $7 7.52% upside $3.5 Benzinga
N/A
Unknown
Piper Sandler
N/A
over 3 years ago $5 -23.19% downside $3.56 Benzinga
N/A

Vicarious Surgical Financial Estimates

Vicarious Surgical Revenue Estimates

Vicarious Surgical EBITDA Estimates

Vicarious Surgical Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $40.43M
Low: $40.43M
High: $40.43M
avg. 0%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $30.63M
Low: $30.63M
High: $30.63M
avg. 0%
Avg: $55.2M
Low: $55.2M
High: $55.2M
avg. 80.19%
Net Income
 
% change YoY
$-7.04M
 
N/A
$89.15M
 
1366.25%
$-71.07M
 
-179.71%
Avg: $-75.23M
Low: $-2.14B
High: $-1.66B
avg. -5.85%
Avg: $-78.93M
Low: $-2.01B
High: $-1.75B
avg. -4.91%
Avg: $-1.13B
Low: $-1.13B
High: $-1.13B
avg. -1342.79%
Avg: $0
Low: $0
High: $0
avg. 100%
EBITDA
 
% change YoY
$-38.55M
 
N/A
$-78.64M
 
-103.98%
$-69.19M
 
12.01%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$2.19
 
N/A
$20.77
 
1048.40%
-$14.7
 
-170.77%
Avg: -$12.7
Low: -$14.7
High: -$11.4
avg. 13.60%
Avg: -$12.7
Low: -$13.8
High: -$12
avg. 0%
Avg: -$7.8
Low: -$7.8
High: -$7.8
avg. 38.58%
Avg: $0
Low: $0
High: $0
avg. 100%
Operating Expenses
 
% change YoY
$38.57M
 
N/A
$80.07M
 
107.59%
$80.66M
 
0.73%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Vicarious Surgical stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of -338.39% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -2.14B, average is -75.23M and high is -1.66B.

What is Vicarious Surgical stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 20.04% in 2025-2028.

We have gathered data from 3 analysts. Their low revenue estimate is $40.43M, average is $40.43M and high is $40.43M.

What is Vicarious Surgical stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 13.04% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$14.7, average is -$12.7 and high is $-11.4.

What is the best performing analyst?

In the last twelve months 1 analysts have been covering Vicarious Surgical stock. The most successful analyst is Adam Maeder.